Conference
A Phase II study of Temsirolimus (CCI-779) in patients with metastatic and/or recurrent endometrial cancer - NCICCTG IND 160
Authors
Oza AM; Elit L; Biagi J; Panasci L; Tonkin K; Tsao M; Dore N; Dancey J; Eisenhauer E; Seymour L
Volume
3
Pagination
pp. 261-261
Publisher
PERGAMON-ELSEVIER SCIENCE LTD
Publication Date
October 1, 2005
Conference proceedings
EJC SUPPLEMENTS
Issue
2
ISSN
1359-6349